The aim of this study is to investigate the utility of IL-6 as a biomarker for differentiating between sepsis and NEC, and between medical and surgical NEC cases, in a large cohort of infants with suspected LOS. This evidence concerns the gene IL6 and necrotizing enterocolitis.